ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,509.01
      0.62%
      US Tech 100
      19,479.20
      0.00%
      Dow Jones
      39,331.85
      0.41%
      Brent Oil
      86.425
      -0.02%
      Bitcoin
      60,918.23
      -1.79%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Antares Pharma Inc (ATRS)

      7. Antares Pharma Inc (ATRS) News

      ATRS

      Antares Pharma (ATRS)

      Antares Pharma Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRS
      DateTimeSourceHeadlineSymbolCompany
      11:19AMiHub NewswireFeaturedBNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth
      02/17/20218:30AMGlobeNewswire Inc.Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      01/11/20218:00AMGlobeNewswire Inc.Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 MillionNASDAQ:ATRSAntares Pharma Inc
      11/23/20204:05PMGlobeNewswire Inc.Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      11/16/20207:06AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      11/12/20208:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      11/10/20204:30PMGlobeNewswire Inc.Antares Pharma to Present at the Jefferies Virtual London Healthcare ConferenceNASDAQ:ATRSAntares Pharma Inc
      11/05/20204:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATRSAntares Pharma Inc
      11/05/20207:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      11/05/20207:00AMGlobeNewswire Inc.Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      10/22/20208:30AMGlobeNewswire Inc.Antares Pharma to Report Third Quarter 2020 Financial and Operating ResultsNASDAQ:ATRSAntares Pharma Inc
      10/01/20208:57AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      10/01/20208:46AMGlobeNewswire Inc.Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.NASDAQ:ATRSAntares Pharma Inc
      09/21/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      09/08/20208:00AMGlobeNewswire Inc.Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment ConferenceNASDAQ:ATRSAntares Pharma Inc
      08/10/20207:00AMGlobeNewswire Inc.Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor RelationsNASDAQ:ATRSAntares Pharma Inc
      08/06/20207:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      08/06/20207:00AMGlobeNewswire Inc.Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance...NASDAQ:ATRSAntares Pharma Inc
      08/03/20207:00AMGlobeNewswire Inc.Antares Pharma and Lunatus Enter Into an Exclusive Distribution Agreement for XYOSTED® in Saudi Arabia and the United Arab E...NASDAQ:ATRSAntares Pharma Inc
      07/30/20207:00AMGlobeNewswire Inc.Antares Pharma to Report Second Quarter 2020 Operating and Financial ResultsNASDAQ:ATRSAntares Pharma Inc
      07/21/20207:00AMGlobeNewswire Inc.First Commercial Product Using Antares Pharma’s Multi-Dose Pen Platform Launches in EuropeNASDAQ:ATRSAntares Pharma Inc
      07/20/20207:00AMGlobeNewswire Inc.Antares Pharma Appoints Patrick Shea Senior Vice President of CommercialNASDAQ:ATRSAntares Pharma Inc
      06/16/20205:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRSAntares Pharma Inc
      06/15/20207:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/15/20207:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/15/20207:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/15/20207:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/15/20207:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/15/20206:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRSAntares Pharma Inc
      06/11/20207:00AMGlobeNewswire Inc.Antares Pharma to Present at the Raymond James Human Health Innovation ConferenceNASDAQ:ATRSAntares Pharma Inc
       Showing the most relevant articles for your search:NASDAQ:ATRS